Arkansas 2022 Regular Session

Arkansas House Bill HR1039 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1
2	2	AJR040 3/1/2022 1:10:42 PM AJR040
3	3
4	4	State of Arkansas 1
5	5	93rd General Assembly 2
6	6	Fiscal Session, 2022 HR 1039 3
7	7	4
8	8	By: Representative C. Fite 5
9	9	6
10	10	HOUSE RESOLUTION 7
11	11	A RESOLUTION RECOGNI ZING THE FIRST WEEK OF MAY 2022 8
12	12	AS TARDIVE DYSKINESI A AWARENESS WEEK IN ARKANSAS. 9
13	13	10
14	14	11
15	15	Subtitle 12
16	16	A RESOLUTION RECOGNIZING THE FIRST WEEK 13
17	17	OF MAY 2022 AS TARDIVE DYSKINESIA 14
18	18	AWARENESS WEEK IN ARKANSAS. 15
19	19	16
20	20	17
21	21	WHEREAS, many people who have a serious chronic mental illness such as 18
22	22	schizophrenia, bipolar disorder, or severe depression, or who have a 19
23	23	gastrointestinal disorder such as gastroparesis or symptoms such as nausea 20
24	24	and vomiting, require treatment with medications t hat work as dopamine 21
25	25	receptor blocking agents, including antipsychotics; and 22
26	26	23
27	27	WHEREAS, while ongoing treatment with these medications can be very 24
28	28	helpful and even lifesaving, it can also lead those undergoing treatment to 25
29	29	experience tardive dyskinesia ; and 26
30	30	27
31	31	WHEREAS, tardive dyskinesia is a movement disorder characterized by 28
32	32	random, involuntary, and uncontrolled movements of muscles in the face, 29
33	33	trunk, and extremities ; and 30
34	34	31
35	35	WHEREAS, tardive dyskinesia can develop months, years, or decades after 32
36	36	a person starts taking dopamine receptor blocking agents, even after he or 33
37	37	she has discontinued use of those medications, and is often permanent; and 34
38	38	35
39	39	WHEREAS, it is estimated that more than six hundred thousand (600,000) 36 HR1039
40	40
41	41	2 3/1/2022 1:10:42 PM AJR040
42	42
43	43
44	44	Americans suffer from tardive dyskinesia, and the National Alliance on Mental 1
45	45	Illness reports that one (1) in every four (4) patients receiving long -term 2
46	46	treatment with antipsychotic medication will experience tardive dyskinesia ; 3
47	47	and 4
48	48	5
49	49	WHEREAS, tardive dyskinesia research has resulted in recent s cientific 6
50	50	breakthroughs, including two new treatments approved by the United States 7
51	51	Food and Drug Administration; and 8
52	52	9
53	53	WHEREAS, tardive dyskinesia is often unrecognized, and patients 10
54	54	suffering from the disorder are sometimes misdiagnosed, leading the Ame rican 11
55	55	Psychiatric Association to recommend heightened awareness of and regular 12
56	56	screening for TARDIVE DYSKINESIA in patients taking DRBAs ; and 13
57	57	14
58	58	WHEREAS, tardive dyskinesia Awareness Week is recognized in many states 15
59	59	across the country during the first week of May each year, 16
60	60	17
61	61	NOW THEREFORE, 18
62	62	BE IT RESOLVED BY THE HOUSE OF REPRESENTATIVES OF THE NINETY -THIRD GENERAL 19
63	63	ASSEMBLY OF THE STATE OF ARKANSAS: 20
64	64	21
65	65	THAT the House of Representatives recognize the first week of May 2022 22
66	66	as Tardive Dyskinesia Awareness Week. 23
67	67	24
68	68	25
69	69	26
70	70	27
71	71	28
72	72	29
73	73	30
74	74	31
75	75	32
76	76	33
77	77	34
78	78	35
79	79	36